Peyro-Saint-Paul, H., & Hermitte, F. (2010). Detection of the JAK2V617F mutation with the Ipsogen MutaScreen kit: Absence of JAK2V617F does not mean absence of myeloproliferative neoplasm. American Society of Hematology.
Citação norma ChicagoPeyro-Saint-Paul, Hélène, and Fabienne Hermitte. Detection of the JAK2V617F Mutation With the Ipsogen MutaScreen Kit: Absence of JAK2V617F Does Not Mean Absence of Myeloproliferative Neoplasm. American Society of Hematology, 2010.
Citação norma MLAPeyro-Saint-Paul, Hélène, and Fabienne Hermitte. Detection of the JAK2V617F Mutation With the Ipsogen MutaScreen Kit: Absence of JAK2V617F Does Not Mean Absence of Myeloproliferative Neoplasm. American Society of Hematology, 2010.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.